MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ijgo.71083

Медицинская библиотека · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026

Randomized controlled trial investigating the efficacy of oral azithromycin in preventing perinatal infections in pregnant women undergoing labor induction.

Cao Huimin, Zhou Yan, Gu Ning, Yang Ling, Dai Yimin

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

This study evaluates oral azithromycin's effectiveness in reducing intrapartum and puerperal infection rates in term pregnant women undergoing labor induction to guide antibiotic prophylaxis.

METHODS

This single-center randomized controlled trial enrolled 472 women with term singleton pregnancies undergoing labor induction. The participants were randomly allocated to receive either 2 g of oral azithromycin (n = 236) or no treatment (n = 236). The primary outcome was the overall perinatal infection rate (which includes both intrapartum and/or puerperal infections). Secondary outcomes included maternal and neonatal complications, mode of delivery, and safety parameters. Results analysis adopted an intention-to-treat approach.

RESULTS

The overall perinatal infection rate did not differ significantly between the azithromycin group (16.1%) and the control group (16.9%) (absolute risk difference [ARD] = -0.85%, relative risk [RR] = 0.950, 95% confidence interval 0.633-1.425; P = 0.804). Similarly, the incidence of neonatal infectious diseases showed no significant difference between the two groups (2.5% vs 5.1%, P = 0.149). Both groups had comparable outcomes in mode of delivery, maternal-neonatal complications (epidural analgesia, postpartum hemorrhage, and pre- and post-delivery antibiotic use), total labor duration, neonatal hypoglycemia, neonatal intensive care unit admission, and neonatal antibiotic administration. Maternal outcomes did not differ significantly between groups, although 3.4% (8/236) of women in the azithromycin group reported gastrointestinal symptoms during labor, with a total adverse event rate of 3.8% (9/236, including one case of dizziness).

CONCLUSION

The use of an additional 2 g azithromycin provides no additional benefit in reducing the overall risk of maternal infection and perinatal infection in an already intensive antibiotic prophylactic and well-resourced setting.

CLINICAL TRIAL REGISTRATION: This study was registered in the Chinese Clinical Trial Registry, registration number ChiCTR2300077629, November 14, 2023 (https://www.chictr.org.cn/showprojEN.html).

Для цитирования: Cao Huimin, Zhou Yan, Gu Ning, Yang Ling, Dai Yimin. Randomized controlled trial investigating the efficacy of oral azithromycin in preventing perinatal infections in pregnant women undergoing labor induction.. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2026. DOI: 10.1002/ijgo.71083.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.